Testing a new injection for severe itchy skin disease

This trial is testing a new medication called BxC-I17e, which is given as an injection under the skin, to see if it is safe and helps people with moderate to severe atopic dermatitis (eczema). Some participants will receive the medication at different dose levels, while others will receive a placebo (a dummy injection with no active drug) to compare results. The study will follow participants for several weeks to months to watch for side effects and early signs of whether the treatment works.

Many people with severe eczema don't get enough relief from current treatments like creams and ointments. This trial is exploring whether this new injectable medication could offer a better option for patients whose skin disease is hard to control with standard therapies.